AMRN (STOCKS)
Amarin Corp Plc
$15.350000
+0.110000 (+0.72%)
Prev close: $15.240000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Aaron D. Berg
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $322.04M
- Employees
- 275
- P/E (TTM)
- -9.41
- P/B (TTM)
- 0.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $216.76M |
| Benefits Costs and Expenses | $247.90M |
| Cost Of Revenue | $103.25M |
| Costs And Expenses | $247.90M |
| Gross Profit | $113.51M |
| Operating Expenses | $158.26M |
| Selling, General, and Administrative Expenses | $99.54M |
| Research and Development | $19.16M |
| Other Operating Expenses | $39.55M |
| Operating Income/Loss | -$44.75M |
| Income/Loss From Continuing Operations After Tax | -$33.61M |
| Income/Loss From Continuing Operations Before Tax | -$31.14M |
| Income Tax Expense/Benefit | $2.47M |
| Net Income/Loss | -$33.61M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$33.61M |
| Net Income/Loss Available To Common Stockholders, Basic | -$33.61M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.08 |
| Diluted Earnings Per Share | -$0.08 |
| Basic Average Shares | 1,249,439,000 |
| Diluted Average Shares | 1,249,439,000 |
| Assets | $645.76M |
| Current Assets | $626.02M |
| Inventory | $183.59M |
| Other Current Assets | $442.43M |
| Noncurrent Assets | $19.75M |
| Liabilities | $196.35M |
| Current Liabilities | $179.64M |
| Accounts Payable | $48.15M |
| Other Current Liabilities | $131.49M |
| Noncurrent Liabilities | $16.71M |
| Equity | $449.41M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $449.41M |
| Liabilities And Equity | $645.76M |
| Net Cash Flow From Operating Activities | $25.58M |
| Net Cash Flow From Operating Activities, Continuing | $25.58M |
| Net Cash Flow From Investing Activities | -$11.53M |
| Net Cash Flow From Investing Activities, Continuing | -$11.53M |
| Net Cash Flow From Financing Activities | -$2.60M |
| Net Cash Flow From Financing Activities, Continuing | -$2.60M |
| Net Cash Flow | $11.44M |
| Net Cash Flow, Continuing | $11.44M |
| Comprehensive Income/Loss | -$33.61M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$33.61M |
| Other Comprehensive Income/Loss | $0.00 |